Jin Medical International (ZJYL) Current Assets (2022 - 2025)

Jin Medical International (ZJYL) has reported Current Assets for 4 consecutive years, with $44.1 million the latest figure, recorded in Q3 2025.

• Quarterly Current Assets rose 3.1% year-over-year to $44.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $44.1 million (up 3.1% YoY) and the FY2025 annual result came in at $44.1 million, up 3.1% from the prior year.
• Current Assets climbed to $44.1 million in Q3 2025 per ZJYL's latest filing, from $43.8 million in the prior quarter.
• Over the last five years, Current Assets for ZJYL reached as high as $44.1 million in Q3 2025 and fell as low as $18.9 million in Q3 2022.
• A 4-year average of $35.4 million and a median of $38.2 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2023 — Current Assets soared 64.61% — and 2025, when it climbed 3.1%.
• Year by year, Current Assets stood at $18.9 million in 2022, then soared by 64.61% to $31.1 million in 2023, then surged by 37.6% to $42.8 million in 2024, then increased by 3.1% to $44.1 million in 2025.
• According to Business Quant data, Current Assets over the past three periods registered $44.1 million, $43.8 million, and $42.8 million for Q3 2025, Q1 2025, and Q3 2024 respectively.